Selpercatinib is the first drug from Loxo’s pipeline that Lilly has brought to market. Prior to the acquisition, Loxo won approval of Vitrakvi, which targets a different genetic mutation and is sold by Bayer AG. Mr Hancock was today accused of ‘sh**ging on the taxpayer’ after it was revealed he took his mistress to the G7 summit […]
READ MORE